发明申请
- 专利标题： Morphinan Compounds
- 专利标题（中）： 吗啡化合物
-
申请号： US15068404申请日： 2016-03-11
-
公开(公告)号： US20170037449A1公开(公告)日： 2017-02-09
- 发明人: Roger D. Tung
- 申请人： Concert Pharmaceuticals, Inc.
- 主分类号： C12Q1/28
- IPC分类号： C12Q1/28 ; G01N33/49 ; C07D221/28 ; G01N33/493
摘要：
This disclosure relates to novel morphinan compounds and their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This disclosure also provides compositions comprising a compound of this disclosure and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a σ1 receptor agonist that also has NMDA antagonist activity.
公开/授权文献
- US09868976B2 Morphinan compounds 公开/授权日：2018-01-16
信息查询
